Literature DB >> 11257621

Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods.

S Nakasu1, D H Li, H Okabe, M Nakajima, M Matsuda.   

Abstract

The authors evaluated the predictability of MIB-1 immunohistochemistry for growth and recurrences of meningiomas using two different counting methods: 1) in the area of the highest MIB-1 labeling (HL method) and (2) in randomly selected fields (RS method). The MIB-1 staining indices (SIs) determined by the HL method were approximately twice as high as those by the RS method, and the correlation coefficient between them was high (R = 0.86) in 139 meningiomas when transformed logarithmically. The differences in SIs in histologic grades were significant with either method. Tumor doubling time (Td) was calculated in 22 meningiomas from serial radiologic examinations. The RS method yielded a slightly higher correlation coefficient between log Td and log SI than the HL method. When the authors examined the predictability of recurrence in 112 totally removed meningiomas, the RS method distinguished the recurrent group more definitively. Several benign meningiomas with low SIs by the RS method exhibited focal accumulation of MIB-1-positive cells. Although they were assigned high MIB-1 values by the HL method, these meningiomas did not recur, and therefore obscured the prognostic importance of the MIB-1 value with the HL method. Focal accumulation of MIB-1-positive cells in meningiomas is not likely to correlate with their biologic aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257621     DOI: 10.1097/00000478-200104000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  20 in total

1.  Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.

Authors:  Francesco Maiuri; Marialaura Del Basso De Caro; Felice Esposito; Paolo Cappabianca; Viviana Strazzullo; Guido Pettinato; Enrico de Divitiis
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

2.  Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.

Authors:  Okay Saydam; Ozlem Senol; Tieneke B M Schaaij-Visser; Thang V Pham; Sander R Piersma; Anat O Stemmer-Rachamimov; Thomas Wurdinger; Saskia M Peerdeman; Connie R Jimenez
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

3.  Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolfram Henn; Klaus D Zang; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

4.  Proliferation potential of spinal meningiomas.

Authors:  Florian Roser; Makoto Nakamura; Mattia Bellinzona; Rainer Ritz; Helmut Ostertag; Marcos S Tatagiba
Journal:  Eur Spine J       Date:  2005-05-31       Impact factor: 3.134

5.  Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Authors:  Adriana Olar; Khalida M Wani; Erik P Sulman; Alireza Mansouri; Gelareh Zadeh; Charmaine D Wilson; Franco DeMonte; Gregory N Fuller; Kenneth D Aldape
Journal:  Brain Pathol       Date:  2014-10-29       Impact factor: 6.508

Review 6.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 7.  Criteria for malignancy in gastrointestinal endocrine tumors.

Authors:  Cesare Bordi; Tiziana D'Adda; Cinzia Azzoni; Silvia Pizzi; Lorena Bottarelli; Francesca Mormandi; Tommaso Antonetti; Tu Vinh Luong; Guido Rindi
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 8.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

9.  The prognostic value of progesterone receptor status in meningiomas.

Authors:  F Roser; M Nakamura; M Bellinzona; S K Rosahl; H Ostertag; M Samii
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

Review 10.  Treatment of meningioma: an update.

Authors:  Anthony L D'Ambrosio; Jeffrey N Bruce
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.